Skip to main content
. 2012 Nov 8;24(4):909–916. doi: 10.1093/annonc/mds530

Figure 1.

Figure 1.

Unsupervised clustering of all residual tumors training (A) and validation (B) sets and 76 proteins by the breast cancer subtype: hormone receptor positive (green), HER2 positive (red), and triple receptor negative (blue).